Classic Mikulicz syndrome with systemic involvement in IgG4-RD

A slow change in the face or neck can sometimes be the first clue that something deeper is happening in the body. For some people, these early signs may point to classic Mikulicz syndrome — a rare pattern of organ involvement linked to IgG4-related disease (IgG4-RD).

Because it is uncommon and often misunderstood, many people have questions about what it is, how it’s diagnosed, and how it’s treated. Understanding how classic Mikulicz syndrome with systemic involvement presents and how it fits within IgG4-RD can help make sense of these early changes and what they might mean for your health.

What is classic Mikulicz syndrome with systemic involvement in IgG4-RD?

Classic Mikulicz syndrome with systemic involvement occurs when the body’s immune system causes long-lasting inflammation of the lacrimal glands and the major salivary glands, which produce tears and saliva. These are located near the eyes, cheeks, and under the jaw.

This IgG4-RD clinical profile mostly causes lacrimal and salivary gland disease, but it also affects other organs in the body, such as the lungs, pancreas, and kidneys.

Doctors once thought Mikulicz syndrome was a type of Sjögren’s syndrome. Sjögren’s is an autoimmune disease that attacks moisture-producing glands, causing dry eyes and mouth.

Now, we know these are unique diseases with distinct immune patterns and tissue changes.

Common symptoms

Symptoms vary from person to person, but the most noticeable Mikulicz syndrome symptoms usually involve swelling in the glands that make tears and saliva. This swelling often develops slowly and may last for several months or longer.

Many people first notice fullness around the eyes, cheeks, or under the jaw. The swelling occurs on both sides of the face. Swollen glands may feel firm, but they’re usually not painful. Some people also notice ear or sinus issues linked to nearby swelling.

Note that while dryness in the eyes or mouth can occur, it’s often mild. Some people still produce close to normal amounts of saliva even when the glands are inflamed.

In addition to swelling in the face, other complications of classic Mikulicz syndrome with systemic involvement may involve:

• gastrointestinal issues due to issues with the bile ducts
• diabetes, from problems with the pancreas
• urinary changes due to kidney inflammation and damage
• pulmonary disease

How it differs from head and neck-limited disease

Head and neck-limited disease is another clinical profile of IgG4-RD that is also marked by persistent swelling of the lacrimal and salivary glands. It affects about 20% of people with IgG4-RD.

The main difference is that disease activity in this profile is restricted to the head and neck, while classic Mikulicz syndrome with systemic involvement also impacts other parts of the body.

Classic Mikulicz syndrome with systemic involvement also has a presentation that more closely resembles what was previously known as classic Mikulicz syndrome, in which both lacrimal and salivary glands are affected and usually become enlarged on both sides of the face. Head and neck-limited disease generally affects fewer sets of glands.

How doctors diagnose it

Because classic Mikulicz syndrome with systemic involvement looks similar to other diseases, it can’t be diagnosed from a physical examination alone. Doctors usually use several different kinds of tests before confirming a diagnosis.

A physical examination and medical history are usually the first step. Doctors look for long-lasting swelling in the tear glands near the eyes and the saliva glands along the jaws. Key diagnostic features include swelling that affects both sides of the face and lasts for three months or longer.

To confirm the diagnosis, several tests may be used, including:

• Blood tests: Blood tests measure IgG4 levels. Many patients show higher than normal levels of this immune protein. However, it can’t be used alone to make a diagnosis.
• Imaging scans: CT scans, MRI, or ultrasound can show enlarged glands or tumor-like masses consistent with systemic involvement.
• Biopsy: A small tissue sample taken from a gland or other organs may reveal large numbers of IgG4-producing immune cells and a typical pattern of inflammation and scarring.

These tests can also help rule out other conditions, such as sarcoidosis (an inflammatory disease), certain blood vessel diseases, lymphoma, or other types of cancer.

Treatment options and long-term management

Treatment focuses on reducing inflammation and preventing long-term damage to the affected glands and organs. Many people show improvement quickly after beginning treatment.

Classic Mikulicz syndrome with systemic involvement treatment options include:

• Steroids: These medications often are the first treatment used to shrink swollen glands and control inflammation in other organs.
• Immune-suppressing medicines: Such medications are sometimes used to help control the disease long term.
• Procedures or medications for other organ issues: These may involve replacing the missing pancreatic enzymes and surgery to keep bile ducts open or to help drain urine from the kidneys.

While many people respond well to treatment, long-term follow-up is important because the disease can return or affect other organs over time.